Artificial Intelligence (AI) has evolved to a point, where it can be used to analyse ‘omics data to identify mechanisms of action that underlie health benefits desirable to today’s consumer.
Following the declaration last week that it is to invest in the
food enzyme side to its business, Danish enzyme company Novozymes
yesterday reported 'the best year ever' for 2002 with sales rising
7 per cent from DKK 5,271...